Wobble uridine tRNA modification: a new vulnerability of refractory melanoma

Francesca Rapino1, Pierre Close1,2

  • 1Laboratory of Cancer Signaling, GIGA-Molecular Biology of Diseases, Interdisciplinary Cluster for Applied Genoproteomics (GIGA-R), University of Liège, Liège, Belgium.

Insights

Enzymes modifying wobble uridine (U34) in tRNAs are vital for melanoma survival and targeted therapy resistance. Inhibiting these U34-enzymes offers a new therapeutic strategy for melanoma patients.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Enzymes modifying wobble uridine (U34) of tRNAs (U34-enzymes) are implicated in tumor development.
  • These enzymes regulate key cellular processes, including translation and metabolic pathways.

Purpose of the Study:

  • To investigate the role of U34-enzymes in melanoma survival and response to targeted therapy.
  • To explore the potential of targeting U34-enzymes as a therapeutic strategy for melanoma.

Main Methods:

  • Utilized glycolytic melanoma cell cultures.
  • Investigated codon-specific regulation of HIF1α mRNA translation.
  • Assessed the effect of U34-enzyme depletion on melanoma cell survival and drug resistance.

Main Results:

  • U34-enzymes are crucial for the survival of glycolytic melanoma cultures.
  • These enzymes regulate HIF1α mRNA translation in a codon-specific manner.
  • Depletion of U34-enzymes resensitizes resistant melanoma to targeted therapy.

Conclusions:

  • Targeting U34-enzymes represents a novel therapeutic opportunity for melanoma.
  • U34-enzyme modulation can overcome resistance to existing melanoma treatments.

Related Concept Videos

tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
tRNA Activation02:26

tRNA Activation

8.6K
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.1K
Histone Modification02:32

Histone Modification

4.5K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.5K
Behavior Modification01:21

Behavior Modification

Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
700